8-K filing — enGene Therapeutics Inc. (ENGNW)
Filed: 2026-07-17 AccNo: 0001193125-26-307795 Size: 16 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
8-K filing — enGene Therapeutics Inc. (ENGNW)
Filed: 2026-07-16 AccNo: 0001193125-26-305418 Size: 234 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 16, 2026, 12:06 PM
- Checked
- Jul 16, 2026, 12:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K/A filing — enGene Therapeutics Inc. (ENGNW)
Filed: 2026-06-18 AccNo: 0001193125-26-275815 Size: 202 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgar